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Economic growth depends in large part on technological change. Laws governing intellectual
property rights protect inventors from competition in order to create incentives for them to innovate.
Antitrust laws constrain how a monopolist can act in order to maintain its monopoly in an attempt to
foster competition. There is a fundamental tension between these two different types of laws. Attempts
to adapt static antitrust analysis to a setting of dynamic R&D competition through the use of "innovation
markets" are likely to lead to error. Applying standard antitrust doctrines such as tying and exclusivity
to R&D settings is likely to be complicated. Only detailed study of the industry of concern has the
possibility of uncovering reliable relationships between innovation and industry behavior. One important
form of competition, especially in certain network industries, is between open and closed systems. We
have presented an example to illustrate how there is a tendency for systems to close even though an open
system is socially more desirable. Rather than trying to use the antitrust laws to attack the maintenance
of closed systems, an alternative approach would be to use intellectual property laws and regulations to
promote open systems and the standard setting organizations that they require. Recognition that optimal
policy toward R&D requires coordination between the antitrust and intellectual property laws is needed.
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I.   Introduction 
 
Over the past twenty years macroeconomists have given renewed attention to the 
importance of technological change for economic growth. Since Schumpeter, microeconomists 
have understood that there may be a tradeoff between achieving static efficiency through 
competition and achieving long-run efficiency through optimal investment in research, 
development and diffusion of innovation. Recent empirical research in industrial organization 
demonstrates that the social value generated by new goods is large. This suggests that policies that 
encourage innovation, even perhaps at the expense of short-run market power, may be beneficial.  
 
The traditional roles of antitrust policy and industry regulation have been to promote static 
efficiency. Acknowledgement of the importance of technological change, therefore, raises several 
important questions for antitrust policy.
1  The questions relate to whether and how antitrust policy 
should concern itself with promoting efficient dynamic competition in technological change, 
whether and how the static concerns of traditional antitrust policy should apply in industries with 
rapid technological change, and to what extent courts are capable of dealing with the complexities 
and uncertainties of technological competition.
2 
 
In this paper, we explore several aspects of these questions. First, we consider merger 
policy, one of the most important areas of antitrust enforcement. One argument that has been put 
forth is that antitrust authorities should consider “innovation markets” separately from standard 
product markets and block mergers that significantly increase concentration in such an R&D 
market. We explain how three conditions are necessary to justify such an expansion of traditional 
concerns in mergers. They are: (1) reducing R&D expenditures is undesirable; (2) if there are 
fewer firms performing R&D, there will be less aggregate R&D and fewer new products; and (3) 
it is possible to determine that there are not enough other firms to perform R&D and develop 
                                                 
1 These questions have been the subject of much discussion.  See, e.g, Carlton (2001), (2002), Evans and Schmalensee 
(2001), and Porter (2002). 
2 See Posner (2001) for a discussion of the ability of courts to deal with technologically changing industries, especially 
pp. 276-280.  
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future products to compete with the future products developed by the merged firm. We argue that 
there is no general theoretical or empirical support for any of these three conditions. Therefore, we 
are skeptical of the benefits of expanding antitrust merger enforcement to block mergers that 
concentrate “innovation markets” as a general policy, with the important caveat that there may be 
several special industries where such a policy may be sensible. Moreover, in some cases certain 
types of evidence, which we discuss below, may be available that could justify blocking a merger.  
 
Intellectual property (IP) policy (patents, copyright, trademark, trade secret) conveys 
market power to developers of intellectual property. Antitrust policy determines, in large part, the 
constraints society places on companies with extensive market power. This creates a potential 
fundamental conflict between intellectual property policy and antitrust policy. Intellectual property 
policy conveys market power; antitrust policy constrains its use. Therefore, any application of 
antitrust policy in R&D intensive industries should consider whether it is complementing or 
thwarting the goals of IP policy. If under current antitrust enforcement, IP policy generates the 
amount of market power that creates the optimal incentives for R&D, then any significant change 
in antitrust policy towards R&D intensive industries could lead to sub-optimal R&D investment. 
At a theoretical level, the right question is “is it a good idea to change antitrust enforcement and 
simultaneously alter IP protection to keep R&D incentives the same?” But this is a policy 
adjustment beyond the powers of either antitrust authorities or the courts.  
 
IP policy and other features of high-tech industries such as network externalities and 
economies of scale in R&D make the existence of short-run market power common. The legal 
doctrines and economic analysis that underlie antitrust policy have largely developed without a 
focus on dynamic technological competition. Because of the prevalence of market power in high-
tech industries, it is important to understand the fit between existing policy and the features of 
these industries. The proper application of antitrust doctrines such as predation, tying, and 
exclusive contracts to high-tech industries is an issue of significant importance. These issues have 
received a fair amount of theoretical attention, so we touch on them briefly and only make some 
general observations. We argue that many of the theories that justify these antitrust doctrines also 
apply in high-technology companies, but several additional caveats may apply. First, the factual 
inquiry may be much more difficult, requiring courts to make complex and subtle judgements  
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about disputed technology issues. This makes the process more costly and more prone to errors. 
Second, developing workable rules that provide guidance to companies with market power may be 
very difficult.  
 
We also explore the role for antitrust enforcement to affect dynamic R&D competition that 
attempts to replace existing market leaders. In many high-tech industries, competition is inherently 
dynamic. A single technology may be the winner in the marketplace at one point in time. 
Competitive forces will then be focused on developing new technology that can replace the 
existing winner. Antitrust policy towards companies with market power did not develop with this 
form of competition in mind. The proper role for antitrust policy in making this process work 
effectively has received little attention, but may well be the most important way that antitrust 
policy can affect competition in high-tech industries. We consider this question in the context of 
dynamic, multi-generational platform competition, where participants can choose between 
developing closed and open systems. We argue that winners in early stages of competition often 
have the incentive and ability to close the system and thereby reduce subsequent competition.  
 
We provide some preliminary thoughts on the role for antitrust policy to improve this 
dynamic systems competition. We do not attempt to develop any standards that enforcement 
agencies or courts should adopt, but we do think our theoretical arguments imply that close 
attention should be paid to conduct that creates a proprietary, closed system subsequent to open 
competition. However, policies other than antitrust enforcement may be more effective 
instruments to improve performance. Government subsidization of standards development, 
reduced restrictions on research joint ventures or other forms of research coordination where 
systems are important may be justified. Furthermore, companies that subvert cooperative standard 
setting processes to create their own proprietary, closed systems should face severe penalties.  
 
The remainder of the paper is organized as follows. Section II outlines the essential 
features of R&D competition that form the basis for our subsequent analysis. Section III discusses 
the role of antitrust enforcement for mergers in R&D intensive industries. Section IV discusses the 
scope of monopolization issues in R&D intensive industries. In Section V we discuss multi- 
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generational competition among open and closed systems and discuss its implications for antitrust 
and other policy. Section VI concludes.  
 
 
II.   Characteristics of R&D Competition for Antitrust Policy 
 
Perhaps the single most important characteristic of technology competition is uncertainty. 
Not only is the outcome of any particular R&D project uncertain but so is the impact of successful 
innovation on markets and competition. Anecdotes abound of an industry being transformed by an 
innovation coming from completely unrelated industries, bringing completely new technology into 
an industry.
3 These anecdotes show that basic research can have unanticipated consequences, and 
perhaps more importantly, that the same is true even for very applied, specific research. However, 
it is possible to make too much of these anecdotes. We discuss below a growing body of 
systematic empirical evidence that much innovation comes from within an industry. We note, 
however, that these studies define industries broadly relative to typical market definition used for 
antitrust enforcement.  
 
All policy towards technological competition should take into account the inability to 
foresee perfectly the outcome or impact of R&D. The structure of the patent system can be best 
explained by the inability of government officials to foresee the impact of particular technologies 
on R&D activities. The outputs of R&D are ideas. Once an idea is discovered, the marginal cost to 
society of using the idea is close to zero. Without property rights over ideas, good new ideas 
would be freely employed. Although efficient after the fact, the result may be no return for the 
innovator, reducing the incentive to engage in innovative activity. Patents convey monopoly 
power to innovators who then can charge super-competitive prices for goods that embody the 
patented technology and/or license the technology above the marginal cost of transfer.  
 
If government officials were omniscient, a superior system would be to subsidize R&D 
directly or award prizes to innovators based on the value of the innovation. This would create 
                                                 
3 We note some examples of this in Section III.  
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incentives to engage in innovative activity and avoid the monopoly distortions of the patent 
system. Although we do provide significant subsidies for R&D projects, it is limited by the 
enormous difficulty of  determining the appropriate size of prizes or direct subsidies to specific 
projects.
4  Policy instead is a mixture of subsidies, usually to more basic research by non-profit 
institutions, patents, and other forms of property rights.
5  
 
A characteristic of technology competition closely related to uncertainty is its dynamic 
nature. Not only does the process of R&D take time, but also the goal of technological 
competition is to replace existing technology with new technology, an inherently dynamic process. 
All policy toward technological competition should acknowledge this. Policy based on static 
models of competition must be evaluated with great care before applied to technological 
competition.  
 
High concentration and short-run market power in the product markets that use the ideas 
that result from innovation often characterize R&D intensive industries. There are several reasons 
for this. First, of course, is patent or other IP protection.  Second, R&D investment is usually a 
fixed, sunk cost. The investment will only be justified if these costs can be recovered with the 
expected rents associated with innovation. Many industries other than high tech have significant 
fixed, sunk costs. Transportation industries such as railroads and ships, power plants, and many 
entertainment products such as movies, music recordings, books, and television production all 
have large fixed, sunk costs.
6  It is probably no accident that these industries are or have been 
often regulated, and many have been the subject of some very complicated and famous antitrust 
cases. 
 
Yet another reason for high concentration in R&D intensive industries is demand-side 
scale economies or network externalities. A demand side scale economy or network externality is 
                                                 
4 See Kremer (1998) for a discussion of how a system of prizes might work and the history of innovation prizes. 
5 See Spence (1984) for a model on the tradeoff between patents and subsidies. 
6 R&D intensive industries exhibit endogenous sunk costs because the level of R&D spending is chosen by firms in a 
way that depends on competitors’ R&D expenditures. Sutton (1998) shows how this leads to high levels of 
concentration independent of market size.  
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simply that consumer value for the product increases the greater is other consumers’ presence. 
Direct network effects can generate this – a consumer values a communications network more 
highly as more people join the network. It can also be generated indirectly by supply of 
complementary products. For example, the value of a computer operating system is greater if more 
consumers purchase the same operating system because more applications will be developed for 
the operating system. When this happens, competition among applications is more likely, leading 
to lower prices and higher quality, valuable upgrades to the operating system are more likely, and 
continued customer support can be expected.  Demand-side scale economies lead to concentration 
of technology. If the network effects are large enough it is difficult for a small competing, 
incompatible technology to survive.  
 
The output of R&D, ideas, are primarily not consumed directly, but incorporated into 
goods and services that are consumed. The previous paragraphs followed much of the writing in 
this area by implicitly assuming vertical integration between the R&D stage and the 
commercialization of the innovation. It is possible, and often the case that a monopoly patent 
holder will choose to license its innovation widely. This preserves downstream competition, 
although the downstream firms often face a monopolistically set input price for the licensed 
technology. Licensing to create efficient deployment of a technology can be hampered by 
appropriation problems. If a technology has weak or no patent protection, attempts to license the 
technology run the risk of appropriation by potential licensees. If part of the licensing negotiation 
reveals the innovation, the potential licensee may choose to reject the offer and develop goods or 
services based on the innovation itself. If the risk of appropriation is high absent patent protection, 
the innovator may only be able to earn a return on its technology by commercializing it and 
reaping the benefits of being a first-mover in the market. Appropriation may still occur but 
perhaps only after the innovator has established a position in the market. Thus, the implicit 
assumption of vertical integration is often justified in the absence of adequate patent protection. 
This suggests an often-overlooked benefit of patent protection – it allows for efficient allocation of 
an innovative technology to the companies who can use it most effectively.
7  
                                                 
7 Hall and Ziedonis (2001) demonstrate that patent protection and subsequent licensing allows small semiconductor 
design firms to compete in innovation despite lacking the scale and resources to manufacture.  
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Similarly, although network effects lead to a small number of surviving technologies, the 
technology need not be controlled by a single company. Network externalities lead to a single 
protocol for fax machines, but the protocol is not controlled by a single company, so there can be a 
great deal of technological competition among fax machine suppliers. In many situations, 
however, companies do compete with proprietary, incompatible technologies. Then, network 
effects can lead to concentration of both technology and market power. 
 
We, therefore, do not adopt a view that R&D intensive industries are inevitably 
monopolized and therefore antitrust law can do no more than favor one monopolist over another. 
We do believe that R&D intensive industries are more prone to market concentration and the 
exercise of market power than most others, that there can be significant social value from market 
power in these industries, but that it is not necessarily the case that only one technology must 
survive for efficiency reasons. 
 
The combination of dynamics, uncertainty, and market power leads to one of the most 
important features of many R&D-intensive industries – an important form of competition is in 
R&D to replace the existing technology winner that has static market power with another based on 
improved technology. This form of competition occurs throughout the computer, pharmaceutical, 
and chemical industries, as well as most other R&D intensive industries. This process of “creative 
destruction” or “Schumpeterian competition” is not the type of competition that antitrust 
enforcement typically tries to protect, but assuring the efficiency of this process may be an 




Another feature of R&D competition is that it may involve redundant investment. Any 
type of private investment may involve some degree of rent-stealing from competitors, i.e., part of 
the returns from investment comes from reducing or eliminating the rents available to others. This 
                                                 
8 See Carlton (2002) and Porter (2002) as well as other articles in the "Symposium on The Antitrust Analysis of 
Mergers:  Merger Guidelines v. Five Forces," University of West Los Angeles Law Review (2002) 7.  
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effect may be especially pronounced in some forms of R&D competition. For example, if two 
firms follow similar research programs to develop a patentable technology, it becomes a race and 
the benefits to consumers relative to a single firm engaging in the research may be small. Free 
entry into the race may lead to either too much R&D or too little R&D and the division of the 




III. Merger Policy in R&D-Intensive Industries 
 
With these (mostly) familiar characteristics of R&D competition in place, we can now 
address the role of antitrust policy towards these industries. In this section, we take on the question 
of whether or not it is appropriate to consider "innovation markets" as distinct from product 
markets for the purpose of merger analysis. Gilbert and Sunshine (1995) make this suggestion; 
antitrust authorities have investigated the impact of mergers on R&D; and the US Department of 
Justice (DOJ) has blocked at least one merger on the basis of anticipated reductions in innovation 
using the concept of “innovation markets”.
10  
 
Mergers in R&D intensive industries have become quite common in the past decade. The 
pharmaceutical industry has had several major mergers and numerous smaller acquisitions; 
defense contractors have undergone extensive consolidation, as have telecommunications 
companies. This is in contrast to the 1980s where R&D intensive industries had not been the focus 
of much merger activity.
11  
 
In a free market economy, a voluntary decision of two firms to merge should be made 
because the firms believe that their joint value exceeds the sum of their independent values. This is 
generally because they believe that there are efficiencies associated with combining the two 
companies. However, some mergers can lead to a reduction in competition that causes output to 
                                                 
9 The idea of wasteful competition for rents has been analyzed by economists in many analogous settings.   
10 This was the proposed acquisition of the Allison Transmission Division of General Motors by ZF Friedrichshafen 
AG in 1993. We discuss this case in more detail below. 
11 See Hall (1988) and Pound et al. (1986).  
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decline and consumer prices to rise.
12 It is commonly accepted, as a matter of theory, that a 
reduction in competition from a merger can have these undesirable effects. Large-scale cross-
sectional studies of the relationship between concentration and price suffer from severe 
measurement and causality problems that make it difficult to assess the general relation between 
concentration and pricing. However, there are also several empirical studies of individual 
industries which show that reductions in the number of competitors or increases in market 
concentration can harm consumers by increasing price.
13 Overall, there is both empirical and 
theoretical support for an antitrust policy aimed at preventing mergers that so concentrate an 
existing product market so as to make price increases likely. 
 
Current antitrust enforcement focuses on short-run anticompetitive harm. If the antitrust 
authorities can show that price would rise in the first two years after the merger, the merger is 
likely to be enjoined. Arguments that significant efficiencies will be realized in subsequent years 
are likely to have no impact. And for good reason. Antitrust authorities are acknowledging that 
predicting the future is hard. Future benefits from a merger, as well as future harms, should be 
discounted for time and the likelihood that they will actually occur. Short-run harm to competition 
is more immediate (by definition), and probably more highly predictable. 
 
The potential competition doctrine takes the small step of logic to extend antitrust merger 
review to firms that do not currently compete but might compete in the future in the absence of the 
merger. In theory, the issues are identical to a merger among current competitors. As a practical 
matter, however, one must predict the impact on competition in the more distant future. Questions 
that should be addressed include: if the merger occurs will there be more entry by others? Absent 
the merger, will the potential competition turn into significant actual competition? How will 
competition in the market evolve over the next several years with and without the merger? Since 
predictions like these are quite unreliable and mergers tend to generate efficiency gains, antitrust 
regulators should and do set a high standard before blocking a merger on potential competition 
grounds.  
                                                 
12 There is also a large literature arguing that agency costs can explain many mergers, i.e., a merger that is not value-
enhancing may still be in management’s interest. 
13 See, e.g., Chapter 9 in Carlton and Perloff (2000).  
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If the potential competition doctrine is a small step in economic logic from the usual 
antitrust policy aimed at firms actually competing, then the innovation market doctrine may seem 
to be only another small step removed from the potential competition doctrine. The only 
difference between the two doctrines may seem to be that one is about future competition in an 
existing product market, while the other is about competition in R&D which leads to future 
competition in current or future product markets. Yet, it is no small step in logic to reach the 
conclusion that concentration of an innovation market is undesirable or that antitrust policy should 
seek to block mergers that significantly increase such concentration. 
 
To reach such a conclusion, one must accept the theoretical and empirical validity of the 
following claims: 
1.  Reducing R&D expenditures is undesirable; 
2.  If there are fewer firms performing R&D, there will be less aggregate R&D and 
fewer new products; 
3.  There are not enough other firms to perform R&D and develop future products to 
compete with the future products developed by the merged firm. 
Neither theoretical nor empirical analysis has established the general validity of any of these three 
claims.
14 We will discuss each claim in turn. 
 
A.  Reducing R&D Expenditures is Undesirable 
 
Since R&D expenditure is an input, not an output, it is desirable only because it leads to 
knowledge that ultimately benefits society, as would occur if new products embodying the 
knowledge were produced. As with all inputs, efficiencies can cause output to be produced with 
less inputs; a merger that reduces R&D expenditure may be beneficial if it allows the R&D to be 
conducted more efficiently. Since competing R&D expenditures may be duplicative, a merger that 
eliminates redundancy may lead to the same knowledge produced at lower costs, or even greater 
                                                 
14 This is not from lack of study. There is a large literature on each of these topics. See Cohen and Levin (1989) for a 
large survey covering these and other issues.  
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knowledge at lower costs. The same or increased knowledge would likely be embodied in the 
same or greater number of products, so long as there was no traditional market power problem 
with the merger in the consumer market.
15 Other efficiencies beyond elimination of redundancy 
could be an enhanced interchange of ideas and sharing of resources. Although situations where 
R&D reductions are efficiency enhancing may be hard to identify, it is incorrect to conclude that 
any reduction in R&D is necessarily bad for consumers. It can be a difficult question whether a 
merger that will reduce R&D should be blocked, even if the authorities cannot demonstrate a 
reduction in output.  
 
A comparison to other sources of cost savings in a merger is useful. We would never say a 
merger is anticompetitive simply because it leads to reduced overhead, labor or materials savings. 
It would be necessary to study whether or not there would be output reductions.
16 Possible reasons 
to adopt a different standard with respect to R&D reductions compared to other cost reductions 
would be that it may be difficult to prove the output effect and policy makers may conclude that 
consumers are generally harmed from R&D reductions.  
 
Indeed it is very difficult to measure the output from R&D. This is because the ideas 
generated are idiosyncratic, their value is hard to measure, and the R&D process takes time and 
the outcomes are uncertain. Estimating a production or cost function for R&D would be virtually 
impossible unless one used broad proxies, such as patents issued, for output. 
 
Even if one could show that less R&D would lead to fewer new products, the question still 
remains whether this is bad for society. It is well known that competition may result in either too 
                                                 
15 For example, consider an R&D joint venture by two competitors where both get to share in the cost-reducing 
technology produced by the joint venture, but still compete with each other in the product market. One can show that, 
under some circumstances, the joint venture will invest in the same amount of R&D as each firm would individually 
absent the joint venture. The result of the joint venture is the same cost reduction, the same product market prices, but 
a 50% savings in R&D costs. The joint venture is a Pareto-improvement. 
 
16 If one adopted the reasonable view that overall efficiency (not consumer welfare) was all that mattered, then one 
would look at the net surplus resulting form the merger.  
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few or too many new products. Unlike output restrictions, which cause unambiguous consumer 
harm, a reduction in the rate at which new products emerge may or may not be desirable. This is 
recognized in limited patent length and other aspects of intellectual property policy.   
 
The antitrust treatment of R&D should be viewed in the context of all aspects of 
intellectual property policy. Maybe one could have the same amount of innovation with shorter or 
narrower patents and weaker antitrust enforcement or vice versa. It simply does not follow from 
any theoretical argument that, given current patent policy, using antitrust enforcement to block 
reductions in R&D is good for society.  
 
There is some empirical evidence on this point.
17 For much R&D, it appears that the social 
rate of return exceeds the private one, suggesting that more R&D would be desirable. In addition 
the recent literature on the value of new goods suggests that consumer returns from innovation are 
very large. However, the correct question compares the marginal social return from R&D with the 
marginal private return, yet most of our evidence is on average returns. Even if we accept that 
more R&D would be beneficial (and we tend to hold this belief), there is no evidence to suggest 
that stricter antitrust enforcement is a more cost-effective way to achieve this compared to 
increased patent protection or other changes in IP policy.  
 
One approach that addresses the possible efficiency of eliminating duplicative R&D, and at 
the same time achieves some of the benefits of competition in the output market is a research joint 
venture. Such a joint venture can be either open to any firm that chooses to join or it can be limited 
to only a few firms. The joint venture can provide the fruits of its labors to the participating firms 
that compete in the output market. By making available the R&D input to several rival firms in the 
output market, some of the benefits of competition can be preserved. Although structuring a 
research joint venture can raise complicated issues, it can be a viable substitute to a much less 
competitive output market structure.
18 Antitrust authorities recognize this and have loosened 
enforcement against research joint ventures.  
                                                 
17 See, e.g., Jones and Williams (1998). 
18 See Carlton and Salop (1996).  
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B.  Fewer Competing Firms will Reduce R&D 
There is no consensus in the theoretical or empirical literature that reduced competition 
leads to less R&D and fewer new products. Not all new technology can be patented, so imitation 
and reverse engineering are possible in many industries. For example, some software is protected 
only by copyright, so a software developer can legally implement its own version of innovative 
features in a competitor’s product. If imitation is possible, a more concentrated market can permit 
the innovator to capture more of the value of its innovation. In this way, market concentration 
helps solve the appropriability problem and could increase innovation.  
 
Patent protection can reduce or eliminate the appropriability problem, but it does not solve 
the lack of theoretical consensus on the relation between concentration and R&D activity. Various 
theories predict that competition can have significant impact on R&D activity; the problem is that 
the results can go either way. For Schumpeter (1943), market concentration aids innovative 
activity because large firms can absorb the risks and costs of innovative activity. For Arrow 
(1962), a competitive firm will typically have a greater incentive than an established monopolist to 
invest in R&D since it can gain the entire monopoly profits in the market while the incumbent will 
only gain the incremental monopoly profit from the innovation. This holds if the innovator 
captures the entire market. However, if an innovative entrant and the incumbent compete, then the 
incumbent may have greater incentive to invest to avoid the lost industry profits associated with 
duopoly. 
 
Sophisticated theoretical models of patent races show that competition to discover and 
patent an invention could lead to too much aggregate R&D expenditure. There are two external 
effects of increased R&D investment: it lowers rivals’ payoffs and the innovator does not capture 
all the social value of its invention. These two effects go in opposite directions. The theory 
remains ambiguous and the size of these two effects is difficult to measure in any real setting. 
 
The empirical literature provides no firmer foundation for an antitrust policy designed to 
prevent mergers that will concentrate "innovation markets." Although some early research 
suggested a positive relation between R&D and concentration, subsequent research has failed to  
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confirm this result. In an extensive survey, Cohen and Levin (1989) conclude, “The empirical 
results concerning how firm size and market structure relate to innovation are perhaps most 
accurately described as fragile….these results leave little support for the view that industrial 
concentration is an independent, significant, and important determinant of innovative behavior and 
performance.”  
 
In summary, neither theory nor empirical work provides any general justification for an 
antitrust merger policy aimed at preserving competition in R&D markets. They certainly tell us 
nothing about essential policy issues, such as at what levels of concentration should there be 
concern. Do economists really know so little about R&D and concentration that there is no basis at 
all for an antitrust policy aimed at preventing a reduction in R&D competition? The short answer 
is “yes” but it is important to note that the empirical literature, for the most part, relies on cross-
sectional studies across industries, which cannot control for the impact of industry-specific factors. 
Such studies, like similar ones for price and concentration, do not provide a sound methodology 
for uncovering such a pattern, if one exists. Moreover, industries probably vary too much for one 
theory to fit all.  
 
This means that a study of an individual industry over time could find a stable empirical 
relationship between concentration, R&D activity, and innovation, all else equal. Indeed it is 
precisely the industry in which the merger is proposed that should be studied to see if a pattern 
exists. If no data are available to perform such a study, then there is no other general economic 
literature to justify an antitrust challenge that concentrates R&D. It is precisely when data on 
individual industry behavior are available that the economist should try to use his empirical tools 
to detect whether there is any effect of concentration on R&D competition. 
 
The empirical academic literature on the relationship between concentration and price has 
shifted to industry studies over the past twenty years. In order to identify a relation, there must be 
time series or cross-section variation in concentration. In addition, since this variation is usually 
endogenous, one needs instruments to identify the effect of concentration. This has limited the 
number of industries where such studies can be done. The data problems are more severe with 
R&D. We can think of no good examples where there is useful geographical cross-section  
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variation in R&D – ideas have no geographical boundaries and innovations are typically 
implemented everywhere. One could imagine studies across, say, different classes of 
pharmaceuticals or defense-related R&D projects but the differences in the R&D production 
functions could be difficult to identify. Similar problems exist over time – does R&D go down 
because concentration increased or because the opportunities for technological improvements 
declined? Thus, although industry studies can be appropriate, we think that they could well raise 
difficult empirical issues. 
 
C.  There are not Enough Other Firms to Produce the R&D in the Future 
Of the three logical underpinnings for an antitrust merger policy aimed at preserving 
competition in R&D markets, this one may be the most troublesome. The basic problem is similar 
to the one that arises in the application of the potential competition doctrine where all future 
competitors have to be identified in order to determine whether the elimination of a single one 
would harm competition. Identifying future competitors for a known product strikes us as 
generally pretty hard, especially as the time period lengthens. Identifying future competitors for an 
unknown product is likely to be an order of magnitude more difficult.  
 
In order to identify an "innovation market," one must include the innovation activity of all 
those firms with R&D efforts that might result in products competitive to the ones that the merged 
firm may develop. This means that there typically will be firms in the "innovation market" who do 
not currently compete in any way with the firms that propose to merge. Indeed, because the results 
of R&D are so difficult to predict, the analyst may be unable to determine all, or even most, of the 
relevant firms who might produce competitive products in the future. This problem becomes 
increasingly severe the longer it takes before any new products are expected to come to market 
and the more uncertain and rapidly changing is the industry. 
 
Indeed, it is often impossible to predict which industry, let alone which firm, will develop 
a particular type of new product. R&D in one product has frequently led to unpredictable 
applications elsewhere. For example, Teflon was discovered as a byproduct during an experiment 
on refrigerator gases. Teflon has since been used for a wide variety of applications such as  
 16
microchip packaging, non-stick coatings, and artificial arteries.
 19 Research on dressings for 
wounds led a researcher to discover a new coating that leaves fabric waterproof but breathable. 
The company, Biotex, that developed this product did so as part of its research on artificial hearts 
and is now venturing into the textile business.
20 In 1988, Wayne Matson developed a machine to 
analyze brain chemistry. Soon, it was clear that the machine had other uses and has since been 
used to identify the components of fruit juices.
21 Corning, a glass company, became a leading 
supply of telecommunications equipment based on technology that would have been impossible to 
predict before the fact.  
 
These examples illustrate that it can be hard even to contemplate all the unlikely sources of 
tomorrow’s products. How many economists or lawyers would have predicted even ten years ago 
that R&D in computers, cable, and telecommunications would result in products that compete with 
each other? The implication is that innovation markets will tend to be quite broad so that it is 
unlikely in many cases that a merger should raise concerns about significantly diminishing R&D 
competition. 
 
Despite the entertaining anecdotal evidence about the serendipitous nature of innovation, a 
number of recent studies cast doubt on a general conclusion that innovation is, on average, 
serendipitous. Methe, Swaminathan and Mitchell (1996) show that established firms are often 
sources of major innovations in telecommunications and medicine. Note that the industry 
definition of telecommunications and medicine used in these articles is significantly broader than 
market definitions that are typically used in antitrust policy. Prusa and Schmitz (1991) show that 
new firms have a comparative advantage developing new categories of software while established 
firms have a comparative advantage developing improvements to existing categories of software. 
Tether (1998) shows that although small firms have more innovations per employee, large firms 
develop more important innovations. However, Kortum and Lerner (2000) show that venture 
capital accounts for a disproportionate share of industrial innovation. 
 
                                                 
19 See Wall Street Journal, October 4, 1984. 
20 See Wall Street Journal, October 19, 1984. 
21 See Wall Street Journal, February 5, 1990.  
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Thus, in some limited circumstances, an analyst may be able to identify the firms who are 
likely to be pursuing R&D that will lead to competing products several years in the future. Perhaps 
in some industries such as pharmaceuticals, where R&D is becoming more systematic and there is 
a regulatory pipeline (e.g., FDA) for approval, or defense products, where government funding or 
approval is required, such identification is possible. But the longer the time period, the less 
reliable is the prediction.  Finally, in those rare cases where the analyst can confidently predict that 
a merger will lead to a decline in competition in R&D which, in turn, will lead to a decline in 
competition in new products, it would seem likely that the potential competition doctrine could be 
used to prevent the merger. The use of the potential competition doctrine might involve applying it 
to products that do not now exist but will exist in the future with a high degree of certainty. This 
seems like a logical and straightforward use (or extension) of the potential competition doctrine. 
We prefer the potential competition doctrine to the innovation market approach because the 
potential competition doctrine, unlike the innovation market approach, focuses on the effects in an 
output market of reduced competition (i.e., price, quality, speed of introduction), instead of the 
more general and harder to predict effect of reduced R&D on unspecified future products. 
 
Not all R&D is designed to create new products; much R&D investment is designed to 
lower production cost of existing products or to make incremental improvements to existing 
products. In such situations, it is more likely that an insider rather than an outsider will develop 
such an improvement. Although in these markets, it may be possible to define the set of firms that 
compete in R&D, it is also in these settings that some of the problems identified in the preceding 
sections become most severe. Imagine that two manufacturers of a particular product wish to 
merge. There is no direct antitrust problem in the product market because there are many other 
competitors. But the two firms compete in R&D to produce the product less expensively while 
none of the other product manufacturers compete in R&D. It is exactly in a situation such as this 
where a merger could increase R&D by reducing appropriation risk or eliminating redundancy. 
The impact of successful innovation on product market competition is also unclear in such a 
setting. If the innovation is patented, the diffusion may be same with or without the merger. If it 
cannot be patented, the innovation may be more widely used if there is a merger.  
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D.  Application of the Doctrine 
 
The doctrine that mergers can concentrate an innovation market and harm R&D 
competition has been applied in merger analysis. One of the first such cases was the proposed 
acquisition by ZF Friedrichshafen AG of the Allison Transmission Division of General Motors. 
Allison makes automatic transmissions for certain types of trucks (e.g., refuse trucks) and buses. 
ZF also makes transmissions, including automatic ones, for certain trucks and buses. The U.S. 
Department of Justice (DOJ) issued a complaint to stop the merger in November 1993, and the 
deal then died. In its complaint, the DOJ alleged that the acquisition would reduce competition in 
two product markets, one for refuse trucks and one for transit buses. It also alleged that 
competition would be adversely affected in the worldwide market for innovations in automatic 
transmissions. Specifically, the DOJ was concerned that ZF would not continue to engage in R&D 
in as vigorous a fashion after the merger. 
 
Assume that it would have been possible to allay the competitive concerns about the two 
traditional product markets by having ZF license an independent third party, and further suppose 
that there were at least some efficiency motivating the transaction. The transaction was stopped in 
1993, so consumers have been deprived of eight years of benefits (indeed the DOJ can influence 
the size of the benefits that consumers receive by the type of license arrangement it accepts). As of 
2002, we understand that no significant new products in automatic transmissions have emerged 
from ZF nor has ZF become a more vigorous competitor. In fact, we understand that ZF has 
withdrawn form the refuse truck market. 
 
We do not want to comment on whether it was wise to issue the complaint.
 22 We simply 
point out that that the benefits from R&D that was the concern of the DOJ are highly uncertain 
and difficult to predict. It is therefore useful to follow this case and others like it, to see whether 
consumers ever receive any benefit from the R&D that was the concern of the DOJ or FTC in 
blocking a merger and, if so, when. The expectation of these benefits should be discounted and 
compared to the immediate efficiency benefits that could likely have been achieved by a well-
                                                 
22 Dennis Carlton served as a consultant for GM and ZF.  
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structured settlement. Only by systematically keeping track of the subsequent evolution of 
industries will we be able to decide what are good antitrust merger enforcement policies.  
 
IV.  Monopolization in R&D Intensive Industries 
 
R&D intensive industries are prone to short-run exercise of market power. Patent 
protection, economies of scale in R&D, network effects, and significant horizontal and vertical 
differentiation all can lead to some market power. In many situations single technologies dominate 
the market and sometimes a single firm controls those technologies. 
 
Since this is an inherent feature of R&D-intensive industries, it would be seriously 
misguided to employ the antitrust laws to prevent the exercise of market power in these industries. 
Obviously, not allowing a patent holder to exercise market power would defeat the purpose of the 
patent laws. Even absent patent protection, market power derived from successful R&D creates 
incentives for R&D that are beneficial.   
 
Fortunately, it is a basic tenet of antitrust law that monopoly power is not, by itself, illegal. 
Only certain categories of conduct designed to obtain, extend, or preserve monopoly are illegal. 
The types of conduct that have been successfully challenged include predatory pricing, exclusive 
dealing, and tying.  
 
Since we are generally unconcerned about market power initially obtained through R&D 
investments, we will focus on the role of antitrust policy with respect to conduct that extends or 
preserves legally obtained market power in R&D intensive industries.  
 
Ever since Schumpeter introduced the idea, many commentators have emphasized that 
competition in R&D markets is largely about innovation designed to replace existing firms with 
market power. This dynamic competition has received so much attention that it has several names: 
“Schumpeterian competition,” “creative destruction,” and in the context of computing systems, 
“dynamic platform competition.”  
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It follows that competition policy in R&D intensive industries should focus on the 
performance of this dynamic competitive process. Perhaps we should not worry about the static 
exercise of market power, or even the exercise of static market power over long periods of time, 
but we should worry about firms with static market power distorting the dynamic innovation 
competition for future market power. It does not yet follow, however, that there is a role for policy 
intervention in this process, nor does it follow that antitrust is the best policy tool to regulate this 
process. However, we do think it is an area that merits careful analysis and continued research. We 
take a few preliminary steps in this section.  
 
A current technology leader with market power would like to earn as much rents from its 
intellectual capital for as long as possible. Many of its activities will have an impact on such a 
firm’s ability to sustain its position. They include investment in R&D to develop product 
improvements or next generation products, long-term contracts with customers, tying or bundling, 
changing compatibility with complementary products, cross-licensing technology deals with 
potential competitors, and aggressive pricing.  
 
Some of these actions may reduce the likelihood that a competitor will replace the existing 
market leader, they may reduce R&D investments by potential competitors, and they may reduce 
social welfare. The correct policy response cannot be that a company that has legitimately 
obtained market power through its innovative efforts is under a legal obligation to adopt strategies 
that (someone believes) are in the public interest. It should not always be illegal to undertake a 
strategy that is in the firm’s private interest, simply because there is a different strategy that 
(someone believes) leads to higher consumer welfare. Such a policy would be unworkable, would 
put an impossible burden on innovative firms to evaluate social effects of a multitude of strategies, 
and is completely inconsistent with free market principles.  
 
Throughout antitrust law, courts have identified certain classes of monopoly conduct as 
potentially suspect. In most cases, after certain preconditions are met (such as market power in a 
well-defined antitrust market) courts follow a rule of reason analysis. In some situations, this 
inquiry will simply try to weigh the anticompetitive harm against procompetitive benefits. For  
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some allegations, such as predatory pricing, the plaintiff must make a number of specific showings 
(below cost pricing and likelihood of recoupment).  
 
Analyses and arguments over the choice of the best rule for particular types of conduct 
have filled volumes of law and economic journals. Most agree that the factors to consider include 
the likelihood of incorrectly punishing procompetitive conduct versus the likelihood of failing to 
identify anticompetitive conduct, the costs of different types of mistakes, the social return from 
eliminating the anticompetitive conduct, and the value of explicit guidelines that allow companies 
to evaluate the legality of different conduct.  
 
The question for us becomes what types of rules should apply to conduct by a monopolist 
in an R&D intensive industry that may reduce Schumpeterian competition. For many types of 
conduct, the basic theory underlying conventional antitrust analysis applies to R&D competition 
as well. The comparisons are useful. For example, there is a well-developed theory of exclusive 
dealing where exclusive contracts can lead to less competitive actions by competitors including 
reduced investment, exit or entry deterrence.
23 Similarly a monopolist in an R&D intensive 
industry may sign long-term contracts with customers. This could induce a potential competitor to 
reduce its investment in R&D and could occur when a patent is about to expire and the contracts 
act to deter effective generic entry.
24  
 
Applying the theories of antitrust harm to the R&D setting will usually create a more 
difficult factual inquiry. In most cases, it would be very difficult to develop compelling evidence 
on the level of R&D spending by potential competitors in the “but-for” world – in Section III we 
argued that it may not even be possible to identify who potential R&D competitors are. Even if 
one could identify the likely R&D competitors and their but-for R&D investments, it would be 
difficult to determine the social value of such investment and compare it to any efficiency gain. 
And once again the conflict between monopoly power creating IP policies and antitrust becomes 
evident. Are we better off with patent protection of 20 years and tough antitrust rules that reduce 
                                                 
23 See, e.g., Bernheim and Whinston (1988). 
24 Nutrasweet signed long-term contracts with Coke and Pepsi shortly before its patent expiration.   
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the likelihood of extending the monopoly through exclusive contracts or with patent protection of 
17 years and weak antitrust rules? We have no broad answer to this question. If the conduct has 
the effect of stifling the dynamic process of creative destruction, the social costs may be large and 
antitrust enforcement seems justified. But it might be very difficult to know in a particular setting 
if this is the case. 
 
A similar point applies to using the antitrust theories related to tying and bundling. The 
theoretical arguments of how tying could lead to anticompetitive harm include Whinston (1990), 
Carlton and Waldman (2001), Choi and Stefandis (2001), and Nalebuff (1999). The basic idea in 
all these models is that tying makes it more difficult for an entrant to compete. In Whinston, it 
may be impossible to get to sufficient scale to compete in the tied market and thereby allow a 
monopolist to extend its monopoly power into the tied market. In Carlton and Waldman as well as 
Choi and Stefandis, a similar, but dynamic process makes it more difficult for entrants to compete 
in the tying market, while in Nalebuff the pricing advantage of a bundled product makes it more 
difficult for an entrant to compete in either market.  
 
The basic competitive effect of the monopolist’s strategic behavior of tying or bundling in 
these models is reduced investment by a competitor. In an R&D intensive industry, the strategic 
conduct can therefore reduce competitive R&D investment. As just discussed, applying an 
antitrust theory of harm in an R&D setting can be complicated, especially when the tie involves 
incorporating additional functionality into existing products.  Again the possible harms from 
stifling the innovative process will often be hard to weigh against the possible benefit of raising 




V.  Schumpeterian Competition between Open and Closed Systems 
 
Firms in some R&D intensive industries have to decide whether to make their product 
compatible with complementary component products or to make all components itself.  A firm 
with market power in one or more components of an open system may choose to close its system  
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by creating incompatibilities with other products, thereby reducing competitive R&D investment 
for subsequent generations.  This same choice can appear in non-R&D intensive industries, but 
here the choice could have a great influence on future R&D competition. 
 
The theoretical literature on open versus closed systems considers competition for a single 
generation of the technology but does not focus on competition across many generations.
25 The 
single generation models reveal a tradeoff in the choice between open and closed systems. It is 
more difficult to win with a closed system against an open system, all else equal – the closed 
system must provide better value to consumers than mixing and matching the best components 
across all producers of open system components. However, the gains from winning with a closed 
system may be greater because the closed system provider can earn greater rents under certain 
circumstances.  
 
Placing the closed/open systems choice in the context of multi-period Schumpeterian 
competition can change the tradeoff significantly. We use a simple two-period model of 
Schumpeterian competition in order to compare R&D investment incentives between open and 
closed systems. Here we present an example of the model to demonstrate how a leading 
component firm may choose to close a system in order to deter dynamic competition that could 
replace it.  The sole purpose of the admittedly simple model is to illustrate an overlooked incentive 
for dynamic competition to produce closed systems. 
 
Consider the following model.  There are three components of a system, each of which is 
necessary for the system to have any value to a user. For each component,  three firms compete to 
develop the component. Prior to the first period of R&D, firms that research different components 
can merge in order to develop a closed system. If they do not merge, they each develop a 
component for an open system.  
 
                                                 
25 Contributions to this literature include Besen and Farrell (1994), Economides and Salop (1992), Farrell and Saloner 
(1985), Farrell and Saloner (1992), Katz and Shapiro (1985), and Matutes and Regibeau (1988).  
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In period 1, each firm chooses whether or not to invest in R&D. If it invests in R&D it 
develops a component that has uncertain value to consumers. If a consumer selects an open 
system, he can mix and match among all open components. If he chooses a closed system, he must 
choose the single element of the closed system for each component. Consumers are all identical, 
so each chooses the same system. 
 
We denote the three components of the system by A, B, and C. There are three firms 
(subscripted by 1, 2, and 3) with the capability to develop each component, so there are nine firms 
overall. In order to develop a component, a firm must incur R&D costs of K; in return it develops 
a component that has quality of V/3 + θ , where θ  is a random variable. In our numerical example, 
θ  is a discrete random variable that takes on the value –ε  with probability α, ε  with probability α , 
and 0 with probability 1-2α . Demand for the system is linear with unit demand, and the intercept 
is the total quality of the system V+θ Α +θ Β +θ C, which we denote by Z. If the total price of the 
system is P, demand is V+θ Α +θ Β +θ C-P.   
 
Once each firm makes an R&D investment decision, the outcome become known. We 
assume the following about competition: First, it is winner take-all, so the highest quality system 
gets the entire market. If there is a tie for the highest quality component, each wins with 
probability ½. Second, losing firms drop out of the market, so the quality of their technology does 
not constrain the winner. (Assume that there is an additional small cost of product development so 
that a firm with an inferior quality component chooses not to remain because it will make no 
sales.) Third, if there is an open system, each component producer chooses its price 
simultaneously and non-cooperatively. The equilibrium is for each firm to charge Z/4, quantity is 
Z/4 and each firm earns profits of Z
2/16. If all three firms for a given component engage in R&D, 
the expected quality for that component will equal V/3 + max i θ i where subscript i indicates a 
firm. This equals V/3 + 2α (1-α )ε . 
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Prior to R&D investment decisions, a firm can choose to vertically integrate and develop a 
closed system.
26 They then develop a closed system, i.e, they produce components that are 
compatible with each other but incompatible with any competitors’ components. A closed system 
wins only if the sum of the value of its 3 components exceeds the value of the best open system 
which equals the sum of the value of each of the three best components. Since there are two open 
firms for each component and consumers can mix and match to choose the best of each 
component, the closed system will be disadvantaged. The expected quality of a closed system 
component is simply the expectation of a single draw for a component, which is V/3. For example, 
if α = 1/3, the probability of a closed system winning is approximately 0.24 which is less than the 
1/3 probability of winning for each component in an open system. 
 
Although a closed system is less likely to win, its profits are greater conditional on 
winning. The closed system monopolist will set a price of Z/2 for the entire system. Its profits will 
be Z
2/4, which exceeds the entire open system’s profits of (3/16)Z
2. If  α =1/3, an open component 
has a 50% greater chance of winning, but 25% lower profits conditional on winning. With these 
parameters, in a single period model, the equilibrium is for all firms to choose open system 
components.  
 
However, when one introduces the dynamics of competition, the results can change 
dramatically and favor a closed system. To see this we model a second period of R&D investment. 
This R&D competition is Schumpeterian; if a firm invests, then there is some probability it will 
develop the technology for a component that surpasses the quality of the incumbent monopolist’s 
component. There is no issue of compatibility across generations, i.e., there are no consumer 
switching costs. Prior to period 2, a winning open-component firm from period 1 may try to 
vertically integrate to form a closed system.  
 
In period 2, each firm again chooses whether or not to invest in R&D. To keep the model 
simple, we assume that an investment of k generates a probability γ  that component i will have a 
                                                 
26 To keep the exposition of the model simple, we focus on an equilibrium where there can be at most one firm with a 
closed system.   
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value that surpasses the existing technology by µ . If no improved system is developed, consumers 
will continue to purchase the old system. Again, to simplify the analysis, we assume that the 
incumbent and one other firm have access to this R&D capability for each component. Finally to 
avoid the possibility of mixed strategy equilibria, we assume that the incumbent moves first; it has 
the ability to commit to engage in R&D prior to any challenger. 
 
This game is subject to well-understood forces. An incumbent has less incentive to invest 
as its fear of entry subsides because it is already earns monopoly rents -- it cares only about 
incremental rents, while the entrant can replace the monopolist and earn both the incremental and 
base monopoly rents. Since the incumbent can move first, however, for some parameter values it 
may choose to invest in order to deter the entrant from investment. 
 
For each element of the open system, it is easy to characterize the equilibrium. For low 
levels of k, both invest. As k increases, holding all other parameters constant, the incumbent does 
not invest and the entrant does; as k continues to increase, preemption becomes possible and the 
incumbent invests and the entrant does not. For very high levels of k, neither firm invests. 
 
The key difference between an open and closed system is that in the closed system, an 
entrant for a single component cannot invest in R&D, succeed and thereby displace the incumbent 
unless every other component’s potential entrant also invests in R&D and succeeds. We assume 
that the each first generation component is protected by a patent, so that if a company develops a 
single new component to compete against a closed system, it cannot obtain other components to 
provide a product to consumers.
27 The probability of three innovations is γ
3, so unless γ  is close to 
1, the likelihood of displacing a closed system is small relative to displacing at least one element 
of an open system. Thus, for some parameter values, there will be R&D investment by entrants if 
the incumbent system is open, but there will be no R&D investment by entrants if the incumbent 
system is closed. Closing a system could lead to dramatic reductions in dynamic innovation 
competition.   
                                                 
27 This is an extreme assumption that helps illustrate the basic point dramatically. The assumption can be weakened 
and the same basic forces will still apply. We discuss this point briefly below.  
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If the closed system is unchallenged, the incumbent monopolist will invest in R&D only if 
the incremental profits cover the cost of innovation. Since it does not reap all the benefits of 
product improvement, there will be less R&D investment than is socially desirable. An open 
system is likely to lead to more competitive innovation, but the level of innovation could be 
socially excessive. The motivation of substituting oneself for the existing monopolist as the 
recipient of existing monopoly profits is rent-seeking that has no social value. However, the only 
way to do this is to engage in socially valuable innovative activity.  
 
In many settings, it is possible to convert an open system to a closed system by imposing 
incompatibilities at low cost. In our model, after the winning components are determined in the 
first stage of R&D competition, the winnings firms could choose to create a closed system through 
vertical integration or contractually. If possible, this would allow them to deter competitive 
innovation without having to bear the heightened risk associated with developing a closed system 
in the first stage. 
 
One way to interpret the model is in terms of externalities. The beneficiaries of open 
systems are future consumers and firms that will have R&D opportunities in the future. If all of 
these parties could get together to provide appropriate subsidies and coordinate R&D efforts, 
efficient displacement of the closed system monopolist would occur. Such coordination is, of 
course, impossible. The result is that too little investment in displacing a closed system may occur 
and that there may be an incentive for open system suppliers to coordinate and close their system. 
 
The model is most similar in structure to Nalebuff’s papers on bundling.
28 These papers 
focus on the difficulty for a single product producer to compete against a bundled product. In his 
model, there are no complementarities in demand, but pricing strategies by the incumbent makes 
single product entry less profitable and plays a similar role to the independent uncertainties of 
R&D that drive our model. 
 
                                                 
28 See Nalebuff (1999) and Nalebuff (2000).  
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There are a number of possible extensions to the model. It may be extreme to assume that 
innovation in all three components is necessary to replace the existing technology. If one develops 
a much superior single component, it may be possible to use non-proprietary technology for the 
other components. This may reduce the advantage of a closed system, but not completely. The 
closed system monopolist will have an incentive to devote significant resources to R&D for any 
component where significant competition exists. A closed system monopolist has the ability to 
focus its R&D efforts at the component that is most vulnerable. A single component competitor 
will generate external benefits for other component firms -- unless they can coordinate and 
subsidize the innovative firm, the incumbent’s advantage and ability to deter remains. In addition, 
the incumbent could try to acquire any firm that is successful and incorporate the component into 
its system.  
  
Open systems have additional consumer benefits when there is horizontal differentiation 
among components. Variety of components that are compatible can add significant value. This 
may be another source of welfare loss from closing a system.  
 
The model implies that the benefits to winning with a closed system may be large – short-
run and long-run market power without the need to invest too heavily in R&D to maintain its 
position. This suggests that firms could devote enormous resources in the competition to have the 
winning closed system. The model does not allow variable levels of R&D investment. In a richer 
model, the efficiency question is whether this compensates for the welfare losses from the closed 
system. There are several reasons to think that it would not. First, there may be significant 
diminishing returns of consumer benefits and perhaps even the private benefit from incremental 
spending on R&D or marketing to become the initial winner. If the former is the case, consumers 
do not benefit much from the intense competition to be the monopolist. If the latter is the case, 
expenditures may not be too large.  
 
Second, if initial R&D is very uncertain, no firm may try to innovate with a closed system 
because the probability of beating a mix and match open system would be too small. Each firm 
will instead develop single components or several components as part of an open system. 
However, if at any point one company dominates an important component of the open system, it  
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may have the ability to develop a winning closed system at low cost. If it is technologically 
possible to take the winning component and develop proprietary interfaces with other components, 
then the firm could acquire or develop the other components. The component producers, fearing 
obsolescence may be willing to sell out a low price.  
 
We have developed a story of how Schumpeterian competition between closed and open 
systems could result in too little innovation and continued exercise of static market power. If one 
accepts the logic of the basic story, the next question is whether or not antitrust policy should play 
a role to improve performance. Although the model suggests close scrutiny of mergers or conduct 
that creates a closed system, the exact role for antitrust is not straightforward. It is first necessary 
to define the conduct that is suspect – it certainly cannot simply prohibit offering a closed system, 
nor can investing a great deal in R&D to make the system better than rivals be illegal. In many 
circumstances, closed systems may create consumer value by allowing more effective 
coordination among components and competition to become the winning closed system may be 
effective. Furthermore, the determination of the optimal level of R&D remains elusive, so it does 
not follow that simply because creation of a closed system may reduce R&D that the new level of 
R&D is less than optimal.  
 
One type of conduct that possibly could present an antitrust problem is actions a firm with 
market power takes to make a system closed or more closed.
29 Yet the rule of reason analysis 
needed would be very difficult and require a great deal of technical sophistication by courts. 
Antitrust laws may be too crude a policy tool for dealing with these problems. Maybe subsidies for 
maintaining open systems or for open standard-setting organizations would be more effective.  
 
A second set of policies that may be justified are those which promote open systems 
perhaps through limited subsidies, tax benefits, lessened antitrust restrictions on institutions that 
promote standards, and increased antitrust scrutiny on conduct that subverts such institutions. 
Standard setting can be a critical element in having an open system. Therefore, the strategic 
                                                 
29 Economides and White (1994) discuss antitrust implications of closing a system and explain its relationship to tying 
and exclusive dealing. They do not focus on the impact of closing a system on innovation.  
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subversion of the standard setting process can be especially harmful to competition between open 
and closed systems. In several recent court cases, companies have alleged that a rival participated 
in deliberations of collective standard setting in an effort either to obtain information to file 
patents that could then be asserted against those adhering to the standard or to encourage adoption 
of a technology for which they already had patent rights.
30 These acts occurred despite the reliance 
upon each other by firms in the standard setting process that the standards raised no patent issues. 
The subversion of the setting of open standards can defeat the purpose of having open standards 
and could make it impossible for open systems to survive in competition with closed systems. 
 
IP policy could play a significant role as well. Restrictions on the ability to patent certain 
types of interfaces or limitations on how such a patent can be enforced may be justified. In 





Economic growth depends in large part on technological change. Laws governing 
intellectual property rights protect inventors from competition in order to create incentives for 
them to innovate. Antitrust laws constrain how a monopolist can act in order to maintain its 
monopoly in an attempt to foster competition. Antitrust doctrines have for the most part been 
developed with a static setting in mind. There is a fundamental tension between these two different 
types of laws. Attempts to adapt static antitrust analysis to a setting of dynamic R&D competition 
through the use of "innovation markets" are likely to lead to error. Applying standard antitrust 
doctrines such as tying and exclusivity to R&D settings is likely to be complicated. Only detailed 
study of the industry of concern has the possibility of uncovering reliable relationships between 
innovation and industry behavior. One important form of competition, especially in certain 
network industries, is between open and closed systems. We have presented an example to 
                                                 
30 See, e.g., Micron Technology Inc. v. Rambus Inc., U.S. District Court for District of Delaware, Civil Action No. 
DO-792, Rambus Inc. v. Infineon Technologies, U.S. District Court for the Eastern District of Virginia, Richmond, 
Civil Action NO. 3:00 CV 524, and FTC v. Dell  Computer Corp., 121 FTC 616. Carlton has served as an expert for 
Infineon and Micron.  
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illustrate how there is a tendency for systems to close even though an open system is socially more 
desirable. Rather than trying to use the antitrust laws to attack the maintenance of closed systems, 
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